Chiron slashes flu vaccine production forecast

Share this article:

Chiron Corp., one of only two major makers of the flu vaccine for the United States, cut its 2005 output forecast due to continuing problems with its Liverpool, England, factory.

The company plans to produce 18 million to 26 million doses of the Fluvirin vaccine for the upcoming season. It previously forecast making 25 million to 30 million doses.

Last year, Chiron failed to ship 50 million shots to the U.S., prompting a vaccine shortage and concerns about the most vulnerable receiving shots. The British government shut down the facility on Oct. 5 after Chiron discovered 4 million tainted flu shots.

GlaxoSmithKline could sell as many as 10 million flu shots in the U.S. this flu season, pending Food and Drug Administration approval of its marketing application. Sanofi is expected to supply 60 million shots and MedImmune Inc. of Gaithersburg, MD, is expected to provide 3 million doses of its nasal spray vaccine.

Share this article:

More in News

ACO bill in House would waive 3-midnight requirement for skilled nursing care

Certain Accountable Care Organizations would be able to send Medicare beneficiaries to a skilled nursing facility without a prior hospital stay under a bipartisan bill recently introduced in the House of Representatives.

Increasing staff-to-patient ratios improves nurse safety, researchers find

A law setting mandatory nurse-to-patient staffing ratios has reduced the number of workplace injuries for registered nurses and licensed practical nurses in California, according to recently published findings.

Life Care Centers takes Gold in Transitions category

Life Care Centers takes Gold in Transitions category

Life Care Centers of America has won the Gold Award in the McKnight's Excellence in Technology Awards in the Transitions category.